Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.

Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.
复制标题

DOI:
10.1148/radiol.2021203531
复制
发表时间:
2021-04
期刊:
影响因子:
19.7
通讯作者:
COPDGene Investigators and the COPD Biomarker Qualification Consortium
COPDGene Investigators and the COPD Biomarker Qualification Consortium
中科院分区:
医学1区
文献类型:
--
作者:
Ash SY;San José Estépar R;Fain SB;Tal-Singer R;Stockley RA;Nordenmark LH;Rennard S;Han MK;Merrill D;Humphries SM;Diaz AA;Mason SE;Rahaghi FN;Pistenmaa CL;Sciurba FC;Vegas-Sánchez-Ferrero G;Lynch DA;Washko GR;COPDGene Investigators and the COPD Biomarker Qualification Consortium

文献摘要

参考文献

被引文献

相似文献

肺气肿进展与长期结果之间的关系尚不清楚。确定 CT 肺气肿进展与肺气肿参与者死亡率之间的关系。在两项前瞻性观察性研究 COPDGene(clinicaltrials.gov,NCT00608764)和纵向评估慢性阻塞性肺疾病以识别预测替代终点(ECLIPSE;clinicaltrials.gov.NCT00292552)的二次分析中,使用肺密度第 15 个百分位数的体积调整肺密度在 CT 上测量两个点的肺气肿直方图(以下简称肺密度 perc15)方法。使用 Cox 回归分析肺气肿进展率与全因死亡率之间的关联,并根据种族、性别、基线年龄、包装年数和肺密度、基线和吸烟状况变化、1 秒用力呼气量和 6 分钟步行距离进行调整。在 COPDGene 中,使用 Fine and Gray 方法分析呼吸系统死亡率。 COPDGene 中共有 5143 名参与者(2613 名男性 [51%];平均年龄,60 岁 ± 9 [标准差])和 ECLIPSE 中的 1549 名参与者(973 名男性 [63%];平均年龄,62 岁 ± 8)进行了评估,其中分别有 2097 名(40.8%)和 1179 名(76.1%)患有肺气肿。 COPDGene 的基线成像于 2008 年 1 月至 2010 年 12 月进行,ECLIPSE 的基线成像于 2006 年 1 月至 2007 年 8 月进行。 COPDGene 中 5.5 年±0.6 年后进行随访成像,ECLIPSE 中 3.0 年±0.2 年后进行随访成像,并评估随后 5 年的死亡率。肺密度 perc15 每年下降速度每加快 1 g/L,COPDGene 中的全因死亡率就会增加 8%(风险比 [HR], 1.08; 95% CI: 1.01, 1.16; P = .03),而 ECLIPSE 中的全因死亡率会增加 6%(HR, 1.06; 95% CI: 1.00, 1.13; P = .045)。在 COPDGene 中,肺密度 perc15 变化率同样增加,呼吸系统死亡率增加 22%(HR,1.22;95% CI:1.13,1.31;P < .001)。在患有肺气肿的曾经吸烟者中,CT 发现的肺气肿进展与全因死亡率和呼吸系统死亡率增加相关。
The relationship between emphysema progression and long-term outcomes is unclear. To determine the relationship between emphysema progression at CT and mortality among participants with emphysema. In a secondary analysis of two prospective observational studies, COPDGene (clinicaltrials.gov, NCT00608764) and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE; clinicaltrials.gov. NCT00292552), emphysema was measured at CT at two points by using the volume-adjusted lung density at the 15th percentile of the lung density histogram (hereafter, lung density perc15) method. The association between emphysema progression rate and all-cause mortality was analyzed by using Cox regression adjusted for ethnicity, sex, baseline age, pack-years, and lung density, baseline and change in smoking status, forced expiratory volume in 1 second, and 6-minute walk distance. In COPDGene, respiratory mortality was analyzed by using the Fine and Gray method. A total of 5143 participants (2613 men [51%]; mean age, 60 years ± 9 [standard deviation]) in COPDGene and 1549 participants (973 men [63%]; mean age, 62 years ± 8) in ECLIPSE were evaluated, of which 2097 (40.8%) and 1179 (76.1%) had emphysema, respectively. Baseline imaging was performed between January 2008 and December 2010 for COPDGene and January 2006 and August 2007 for ECLIPSE. Follow-up imaging was performed after 5.5 years ± 0.6 in COPDGene and 3.0 years ± 0.2 in ECLIPSE, and mortality was assessed over the ensuing 5 years in both. For every 1 g/L per year faster rate of decline in lung density perc15, all-cause mortality increased by 8% in COPDGene (hazard ratio [HR], 1.08; 95% CI: 1.01, 1.16; P = .03) and 6% in ECLIPSE (HR, 1.06; 95% CI: 1.00, 1.13; P = .045). In COPDGene, respiratory mortality increased by 22% (HR, 1.22; 95% CI: 1.13, 1.31; P < .001) for the same increase in the rate of change in lung density perc15. In ever-smokers with emphysema, emphysema progression at CT was associated with increased all-cause and respiratory mortality.
DOI: 10.7326/m13-2771
发表时间: 2014-03-04
影响因子: 39.2
作者:
Moyer, Virginia A.
通讯作者: Moyer, Virginia A.
DOI: 10.1016/j.acra.2011.01.011
发表时间: 2011-06-01
期刊: ACADEMIC RADIOLOGY
影响因子: 4.8
作者:
Gietema, Hester A.;Mueller, Nestor L.;Coxson, Harvey O.
通讯作者: Coxson, Harvey O.
DOI: 10.1164/rccm.201705-0860oc
发表时间: 2018-01-15
影响因子: 24.7
作者:
Gonzalez, German;Ash, Samuel Y.;Washko, George R.
通讯作者: Washko, George R.
DOI: 10.1093/biomet/89.3.635
发表时间: 2002-09-01
期刊: BIOMETRIKA
影响因子: 2.7
作者:
Fine, JP
通讯作者: Fine, JP
DOI: 10.1016/s2213-2600(13)70006-7
发表时间: 2013-04-01
影响因子: 76.2
作者:
Coxson, Harvey O.;Dirksen, Asger;Vestbo, Jorgen
通讯作者: Vestbo, Jorgen